FDA Inspection
Fangyinmeng MD Inc.Fangyinmeng MD Inc. – FDA Inspection, Feb 18, 2025
Record Details
This FDA Inspection record concerns Fangyinmeng MD Inc., with an inspection on February 18, 2025, issued by the Los Angeles District Office, covering biologics.
View Company Profile
ID · f1b22615-9620-48c0-909a-a3cf17ec3b05
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1261656
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.55(d)(1)(iii)Documentation--determination, by whom, date
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fangyinmeng MD Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 22, 2021 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Fangyinmeng MD Inc.
- FDA Inspection 1156659 - 2021-10-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.